Respiratory function in children and young adults affected by neurofibromatosis type 1 treated with selumetinib
{{output}}
Background: Plexiform neurofibromas (PNs) are benign tumors that can cause pain, disfigurement, and disability in patients with neurofibromatosis type 1. Selumetinib, a MEK1/2 inhibitor, is the first drug who showed efficacy in i... ...
